Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
0
Neutral
13
Bullish
1
Bearish
0
Neutral
45
Bullish
1
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
13
Bullish
1
Bearish
0
Neutral
13
Bullish
1
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bansisons Tea Industries Limited was established in 1987, focusing on increasing tea plantations and manufacturing.
The company now primarily leases gardens for the plucking of green tea leaves, showcasing a shift from direct agriculture to leasing operations.
Despite limited current direct production involvement, the company maintains its foundational role in the tea industry through strategic garden asset utilization.
Bansisons' business model pivots towards optimizing resource management while benefiting from the established agricultural footprint.
Agricultural Food & other Products
Tea & Coffee
6 Cr
Low Risk
-1.1
29.3
—
9.8
16.55
5.88
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
85.80 | 29 Cr | -22.79 | 0.74 | 0.00 | -5.96 | -5.78 | -2.24 | ||
55.62 | 28 Cr | -5.50 | 0.51 | 0.00 | -9.79 | -2.88 | -3.98 | ||
45.97 | 14 Cr | 20.28 | 0.69 | 0.00 | 4.22 | 6.18 | 1.52 | ||
6.50 | 13 Cr | -15.20 | 0.40 | 0.00 | -1.37 | -0.31 | -1.06 | ||
9.64 | 6 Cr | -1.14 | 9.81 | 0.00 | -907.58 | -907.58 | -368.49 | ||
1.23 | 5 Cr | -77.83 | 0.12 | 0.00 | 0.37 | 0.45 | -0.16 | ||
14.82 | 4 Cr | -18.54 | 0.24 | 0.00 | -1.28 | -0.97 | -1.26 | ||
| Median: 7 Co. | — | 14.82 | 13 Cr | -15.20 | 0.51 | 0.00 | -1.37 | -0.97 | -1.26 |
NOVYRA PHARMACHEM LIMITED (BANSTEA) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bansisons Tea Industries Limited was established in 1987, focusing on increasing tea plantations and manufacturing. The company now primarily leases gardens for the plucking of green tea leaves, showcasing a shift from direct agriculture to leasing operations. Despite limited current direct production involvement, the company maintains its foundational role in the tea industry through strategic garden asset utilization. Bansisons' business model pivots towards optimizing resource management while benefiting from the established agricultural footprint.
Over the past 52 weeks, NOVYRA PHARMACHEM LIMITED has traded between a low of ₹5.88 and a high of ₹16.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
NOVYRA PHARMACHEM LIMITED has a market capitalization of approximately 6.10. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
NOVYRA PHARMACHEM LIMITED’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 6.10 Cr, NOVYRA PHARMACHEM LIMITED is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
NOVYRA PHARMACHEM LIMITED operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of NOVYRA PHARMACHEM LIMITED is -1.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
